Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3340 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Datopotamab Deruxtecan February 20, 2025 Study Says Gold Particles Injected into Tumors May Improve Cancer Patients’... June 29, 2021 Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not... April 8, 2025 Cancer, COVID-19, and Competing Threats to Indigenous Health July 20, 2020 Load more HOT NEWS Partnering with Small Business to Advance Innovation in Cancer Research and... Most Cases of Venous Thromboembolic Events, Elevated Aminotransferases, and Interstitial Lung... Worse Survival Observed Among Patients Diagnosed with Cancer During the First... EMA Recommends Extension of Therapeutic Indications for Zanubrutinib
